Leadership Overview
Rho has 4 executives leading key functions including financial strategy, operational delivery, technology integration, and medical oversight.
Committed to advancing global clinical research, Rho prioritizes scientific collaboration and efficient trial execution to accelerate product approvals across diverse therapeutic areas like neurology and immunology.
Committed to advancing global clinical research, Rho prioritizes scientific collaboration and efficient trial execution to accelerate product approvals across diverse therapeutic areas like neurology and immunology.
Leadership Roles at Rho
Michael Szarowicz - Chief Financial Officer
Michael Szarowicz, the Chief Financial Officer at Rho, directs all fiscal planning and capital allocation strategies to support global clinical development initiatives. Overseeing the financial health of the organization, the Chief Financial Officer ensures that resource distribution aligns with the rigorous demands of complex trial execution. This leadership role involves managing long-term investment in biometrics and regulatory infrastructure to maintain competitive market positioning. By optimizing budgetary frameworks, Michael Szarowicz directly impacts the ability of the company to scale operations across North American and international markets. Ultimately, Szarowicz secures the financial stability required to foster innovation in neurology and respiratory research, ensuring that every clinical project receives the necessary funding to reach successful completion while maintaining strict adherence to quality assurance standards and corporate governance protocols.
Alena Hammond - Chief Operating Officer
Alena Hammond, the Chief Operating Officer at Rho, manages the end-to-end clinical delivery processes and operational workflows that define the company's service model. Overseeing the integration of clinical teams and project management offices, the Chief Operating Officer ensures that trial execution remains efficient and compliant with global regulatory standards. This leadership role involves streamlining cross-functional collaboration between biometrics, quality assurance, and site management departments. By refining operational methodologies, Alena Hammond directly impacts the speed and accuracy of data collection in therapeutic areas such as pain and psychiatry. Ultimately, Hammond drives the expansion of operational capacity, ensuring that the organization meets the evolving needs of sponsors and investigators while maintaining a consistent focus on patient safety and high-quality research outcomes across all global clinical development programs.
Biljana Djordjevic - Technology Chief of Staff
Biljana Djordjevic, the Technology Chief of Staff at Rho, architects the digital infrastructure and technological systems that power modern clinical trial management. Overseeing the implementation of advanced data platforms, the Technology Chief of Staff ensures that internal teams possess the tools necessary for precise biometrics and regulatory reporting. This leadership role involves aligning technical capabilities with the broader mission of delivering smarter, data-driven trials. By modernizing the digital ecosystem, Biljana Djordjevic directly impacts the efficiency of clinical delivery and the reliability of research outcomes. Ultimately, Djordjevic supports the strategic integration of new software solutions, enabling the company to maintain a technological edge in the competitive CRO landscape while facilitating seamless communication between global research teams and external partners involved in complex therapeutic development.
Andrew Feigin - Chief Medical Officer
Andrew Feigin, the Chief Medical Officer at Rho, provides the scientific leadership and medical expertise required to guide complex clinical development programs. Overseeing the medical monitoring and safety assessment functions, the Chief Medical Officer ensures that all trials adhere to the highest standards of clinical integrity and patient welfare. This leadership role involves collaborating with regulatory strategy teams to navigate the approval pathways for neurology, immunology, and other critical therapeutic areas. By providing clinical oversight, Andrew Feigin directly impacts the scientific rigor and success rates of the research portfolio. Ultimately, Feigin shapes the medical strategy of the organization, ensuring that every trial design reflects current clinical best practices and addresses the specific needs of patients, investigators, and sponsors within the global healthcare research environment.
Explore Leadership Teams in Business Services
Element Materials Technology is a global testing, inspection, and certification company serving highly regulated and safety-critical industries. It provides materials testing, product qualification, calibration, certification, and related technical services to help organizations ensure their products are safe, compliant, sustainable, and ready for market. The company works across the product lifecycle, from research and development through regulatory approval and production.
Company Leadership RJ
JP
JC
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nations future. Primarily supported by the U.S. Department of Energys (DOE) Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research.
Company Leadership AR
PO
JL
Discovery Life Sciences is the global market leader in biospecimen analysis, procurement, distribution, and scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery's globally recognized sequencing and bioinformatics division that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Driven by science, the Discovery team engages with customers in an innovative, consultative approach to overcoming obstacles and reaching a faster end result. Discovery Life Sciences is headquartered in Huntsville, Alabama.
Company Leadership GH
SH
ECRI is an independent, nonprofit organization dedicated to advancing the safety, quality, and cost-effectiveness of healthcare across all settings. With a strong focus on patient safety, evidence-based practices, and technology decision support, ECRI is widely recognized and trusted by healthcare leaders and government agencies around the world. For over fifty years, ECRI has earned its reputation through integrity, rigorous research, and a steadfast commitment to independence, supported by strict conflict-of-interest policies. It remains the only organization globally to perform independent evaluations of medical devices, with testing laboratories located in both North America and the Asia Pacific region. ECRI is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality and is a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. In 2020, the Institute for Safe Medication Practices (ISMP) officially became an affiliate of ECRI.
Company Leadership
DK
JN
Frequently Asked Questions Regarding Rho Top Executives and Leadership Team
